DecisionPoint™ IR 2026 · CPD Programme
DecisionPointTM
Resources
References & further reading for each webinar in the 2026 Interventional Radiology CPD series.
Each session in the DecisionPoint™ IR series is supported by a curated reference list, selected by the faculty panel. Use these to deepen your understanding, explore the primary evidence, and support your own practice-based learning.
Webinar 01 · 12 May 2026 · On Demand
Pulmonary Embolism: Towards a Unified Clinical Framework
Session overview
References & Further Reading
This opening session brought together interventional radiology, pulmonology, cardiothoracics and emergency medicine to examine how contemporary PE management is being redefined — bridging guideline and bedside practice across disciplines.
Watch the On-Demand Webinar ›01
Konstantinides SV, Meyer G, Becattini C, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2020;41(4):543–603.
doi: 10.1093/eurheartj/ehz405
doi: 10.1093/eurheartj/ehz405
02
Piazza G, Hohlfelder B, Jaff MR, et al. A Prospective, Single-Arm, Multicenter Trial of Ultrasound-Facilitated, Catheter-Directed, Low-Dose Fibrinolysis for Acute Massive and Submassive Pulmonary Embolism: The SEATTLE II Study. JACC Cardiovasc Interv. 2015;8(10):1382–1392.
doi: 10.1016/j.jcin.2015.04.020
doi: 10.1016/j.jcin.2015.04.020
03
Sista AK, Horowitz JM, Tapson VF, et al. Indigo Aspiration System for Treatment of Pulmonary Embolism: Results of the EXTRACT-PE Trial. JACC Cardiovasc Interv. 2021;14(3):319–329.
doi: 10.1016/j.jcin.2020.09.053
doi: 10.1016/j.jcin.2020.09.053
04
Provias T, Dudzinski DM, Jaff MR, et al. The Massachusetts General Hospital Pulmonary Embolism Response Team (MGH PERT): Creation of a Multidisciplinary Program to Improve Care of Patients With Massive and Submassive Pulmonary Embolism. Hosp Pract (1995). 2014;42(1):31–37.
doi: 10.3810/hp.2014.02.1089
doi: 10.3810/hp.2014.02.1089
Webinar 02 · 11 June 2026 · On Demand
Men’s Health & BPH: The Case for Prostatic Artery Embolisation
Session overview
References & Further Reading
This session explored prostatic artery embolisation as a minimally invasive alternative to surgery for symptomatic benign prostatic hyperplasia — examining patient selection, technique, outcomes, and the interventional-urology collaborative model.
Watch the On-Demand Webinar ›01
Sapoval M, Thiounn N, Descazeaud A, et al. Prostatic artery embolisation versus medical treatment in patients with benign prostatic hyperplasia (PARTEM): a randomised, multicentre, open-label, phase 3, superiority trial. Lancet Reg Health Eur. 2023;31.
PMC12155755
PMC12155755
02
Delazar S, Azadnajafabad S, Firouznia K, et al. Outcomes of Prostatic Artery Embolization for Treating Benign Prostatic Hyperplasia Symptoms: A Prospective Single-Center Study. Health Sci Rep. 2025;8(3):e70565.
doi: 10.1002/hsr2.70565
doi: 10.1002/hsr2.70565
03
Iossa V, Punzi E, Pandolfo SD, et al. Prostate Artery Embolization (PAE) in the Treatment of Benign Prostatic Hyperplasia: A Case Series and Narrative Review. J Clin Med. 2025;14(11):3775.
doi: 10.3390/jcm14113775
doi: 10.3390/jcm14113775
04
Altman R, et al. Comparing prostatic artery embolization to surgical and minimally invasive procedures for the treatment of benign prostatic hyperplasia: a systematic review and meta-analysis. BMC Urol. 2024;24:22.
doi: 10.1186/s12894-024-01409-4
doi: 10.1186/s12894-024-01409-4
05
Bhatia S, et al. Prostatic Artery Embolization: Mid- to Long-Term Outcomes in 1,075 Patients. J Vasc Interv Radiol. 2024;36:456–466.
06
Fischer H, Suleman F, Ahmad S. Outcomes of prostate artery embolisation for benign prostatic hyperplasia in 10 cases at Steve Biko Academic Hospital. S Afr J Radiol. 2019;23(1):6 pages.
doi: 10.4102/sajr.v23i1.1349
doi: 10.4102/sajr.v23i1.1349
07
Govedarica S, Raškovic A, Vojinov S, et al. Factors Associated with Health-Related Quality of Life in Patients with Benign Prostatic Hyperplasia Undergoing Pharmacological Treatment: A Cross-Sectional Study. Medicina. 2025;61(12):2244.
doi: 10.3390/medicina61122244
doi: 10.3390/medicina61122244
08
Mouli S, Salem R, McClure TD. Prostate Artery Embolization for Benign Prostatic Hyperplasia. J Urol. 2024 Jul;212(1):216–219.
09
Park S, Lee KS, Choi M, Lee M. Factors associated with quality of life in patients with benign prostatic hyperplasia, 2009–2016. Medicine. 2022;101(36):e30091.
doi: 10.1097/MD.0000000000030091
doi: 10.1097/MD.0000000000030091
10
Zubair A, Davis S, Balogun DI, et al. A Scoping Review of the Management of Benign Prostate Hyperplasia in Africa. Cureus. 2022;14(11):e31135.
doi: 10.7759/cureus.31135
doi: 10.7759/cureus.31135
11
AUA Guideline: Management of LUTS attributed to BPH (amendment 2023/2024); EAU Guidelines on Non-neurogenic Male LUTS (2026); McConnell JD et al. N Engl J Med. 2003 (MTOPS); Roehrborn CG et al. Eur Urol. 2010 (CombAT).
Medical Education Network
Independent · Free Access · Sub-Saharan Africa
An independent, free-to-use clinical education resource for healthcare practitioners across sub-Saharan Africa. Peer-reviewed content, no paywalls, aligned to SDG 2030 health mandates.
Aligned to SDG 2030 Health Mandates
CPD Programmes
Opportunities
Subscribe
Policies
© 2026 Medical Education Network. All rights reserved. Content is for educational purposes only and does not constitute medical advice.
